Abstract
Summary
ML (Mammary Leukemia) cellular antigen, defined by specific cytotoxic antisera, is present on the cells of mammary tumors of MTV-infected mice and on the cells of some DBA/2 leukemias (ML+ leukemias). Transplants of ML+ leukemias are rejected by genotypically histocompatible mice not infected with MTV, but not by MTV-infected mice of the same genotype. Heightened resistance to transplants of mammary tumors can be transferred to recipient mice by immunologically competent cells from donors that have rejected ML+ transplanted leukemias.
Get full access to this article
View all access options for this article.